NCT00124150View on ClinicalTrials.gov

Intravenous Magnesium Sulfate in Aneurysmal Subarachnoid Haemorrhage (IMASH)

PHASE3CompletedINTERVENTIONAL
Enrollment

327

Participants

Timeline

Start Date

June 30, 2002

Primary Completion Date

December 31, 2008

Study Completion Date

June 30, 2009

Conditions
Subarachnoid Hemorrhage
Interventions
DRUG

Intravenous magnesium sulfate infusion

80mg per day

Trial Locations (1)

852

Department of Surgery, The Chinese University of Hong Kong, Hong Kong

All Listed Sponsors
lead

Chinese University of Hong Kong

OTHER

NCT00124150 - Intravenous Magnesium Sulfate in Aneurysmal Subarachnoid Haemorrhage (IMASH) | Biotech Hunter | Biotech Hunter